During the past decade, MVZ Nordhausen gGmbH, Praxis Dr. Grafe conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "MVZ Nordhausen gGmbH, Praxis Dr. Grafe" #1 collaborator was "German Breast Group" with 1 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "MVZ Nordhausen gGmbH, Praxis Dr. Grafe" are "Breast Cancer" (1 trials) and "Triple Negative Breast Cancer" (1 trials). Many other conditions were trialed in "MVZ Nordhausen gGmbH, Praxis Dr. Grafe" in a lesser frequency.

Most popular intervention types in "MVZ Nordhausen gGmbH, Praxis Dr. Grafe" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody" (1 trials), "Nab-Paclitaxel" (1 trials), "Placebo" (1 trials), "trastuzumab" (1 trials) and "trastuzumab emtansine" (1 trials). Other intervention names were less common.

The vast majority of trials in "MVZ Nordhausen gGmbH, Praxis Dr. Grafe" are 2 trials for "All" genders.

Currently, there are NaN active trials in "MVZ Nordhausen gGmbH, Praxis Dr. Grafe". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in MVZ Nordhausen gGmbH, Praxis Dr. Grafe, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in MVZ Nordhausen gGmbH, Praxis Dr. Grafe, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".